查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864799

主動脈瘤市場按治療方法、動脈瘤類型、最終用戶、器械類型、適應症、患者年齡層和性別分類 - 全球預測 2025-2032 年

Aortic Aneurysm Market by Treatment Modality, Aneurysm Type, End User, Device Type, Indication, Patient Age Group, Gender - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，主動脈瘤市場規模將達到 95.3 億美元，複合年成長率為 8.97%。

主要市場統計數據
基準年 2024 47.9億美元
預計年份：2025年 52.2億美元
預測年份：2032年 95.3億美元
複合年成長率 (%) 8.97%

全面介紹影響主動脈瘤治療和相關人員決策的臨床、技術和治療方案發展動態。

主動脈瘤的治療融合了外科手術創新、人口結構變化和不斷發展的醫療服務模式。近年來，臨床實務穩步轉向微創手術，成像技術和醫療設備也取得了長足進步，圍手術全期風險降低的重要性日益凸顯。這些趨勢，加上人口老化和心血管合併症負擔加重，在持續推動臨床需求的同時，也促使人們更加關注治療方法的安全性、長期療效以及成本效益。

深入分析臨床創新、不斷變化的醫療環境和監管趨勢如何重塑相關人員對主動脈瘤治療的認知範式。

主動脈瘤的治療格局正在經歷變革，這主要得益於技術的成熟、治療環境的改變以及相關人員對價值的重新定義。微創血管內修復術已從一種小眾替代方案發展成為多種解剖結構中的標準治療方法，這得益於影像學、導航系統以及模組化血管支架設計的進步，這些技術能夠到達以往無法手術的部位。這些進步，加上圍手術全期最佳化技術和加速復健通訊協定的改進，正在透過縮短住院時間和減少手術相關併發症來改變臨床治療格局。

深入分析2025年實施的關稅調整對主動脈瘤治療生態系中醫療設備採購、生產策略和購買決策的影響。

2025年的關稅調整為參與主動脈瘤治療的醫療設備製造商、醫療系統和經銷商的供應鏈引入了一個新的變數。許多用於血管內和開放手術的器械和組件都來自全球各地，進口關稅的變化可能導致血管支架、合成導管和輔助輸送組件的到岸成本上升。這些成本壓力波及整個採購流程，迫使醫院供應鏈團隊重新談判合約、重新評估供應商多元化策略，並評估某些生產和滅菌流程在地化的可行性。

透過對治療方法、解剖結構複雜性、臨床環境和患者人口統計特徵進行細分分析，指導制定切實可行的臨床和商業策略。

細分市場分析揭示了影響治療方案選擇、器材需求和醫療機構採納的不同臨床管道和商業性因素。基於治療方法，臨床醫師會考慮患者的解剖結構和生理耐受力，權衡血管內修復與開放性手術。血管內技術擴大採用具有先進輸送平台的血管支架系統來擴大應用範圍，而開放手術則繼續依賴生物導管和合成血管移植物，其耐久性和特定的解剖結構要求決定了手術方式。

區域評估揭示了醫療保健基礎設施、報銷方式和臨床實踐的差異如何影響全球主要地區的主動脈瘤治療

區域差異導致臨床實踐、基礎設施和監管要求有顯著差異，進而影響主動脈瘤治療的實施和產品商業化。在美洲，微創手術備受重視，並擁有完善的公共和私人醫療保險體系。先進的影像網路和高容量的三級醫療中心支援新型血管內移植物和複雜開窗解決方案的快速應用，同時，門診也擴大承擔低風險的擇期手術病例。

針對醫療設備製造商的行業特定概述：創新管道供應鏈敏捷性和證據生成，以塑造競爭優勢

主動脈瘤領域的企業策略以持續創新、臨床證據的累積和業務規模的擴大為核心。領先的器械開發商正優先投資於新一代血管支架結構、低輪廓輸送系統和材料科學，以改善長期療效並擴大解剖覆蓋範圍。器械創新者與契約製造或影像技術公司之間的策略合作日益普遍，從而能夠開發出植入性能與先進導航和術中成像技術相結合的解決方案。

為協調產品開發、供應鏈韌性和以金額為準化，以加速產品推廣和臨床應用，提出切實可行的策略建議。

產業領導者應採取多管齊下的策略，使產品創新與醫療服務趨勢、監管預期和採購實踐相契合。首先，優先發展模組化和解剖結構適應性強的器械平台，以降低手術複雜性，擴大微創治療的適用人群，從而促進其在各種醫療機構中的廣泛應用。其次，產生可靠的真實世界數據（RWE），並投資於註冊登記，以提高支付方的接受度，檢驗長期安全性，並推動基於臨床實踐實際情況的產品迭代改進。

本文清晰地描述了用於獲取主動脈瘤治療臨床、商業和供應鏈洞察的定性和定量相結合的研究方法。

本執行摘要的調查方法融合了定性和定量方法，以確保得出嚴謹且以證據為基礎的研究結果。關鍵資訊來源包括對血管外科醫生、介入醫生、醫院採購人員和醫療設備監管專家的訪談，以了解當前的臨床實踐、器械偏好和實施障礙。除了這些臨床層面的觀點外，還與供應鏈和商業負責人進行了討論，以了解生產方面的考慮、分銷動態以及近期貿易政策的影響。

簡潔結論摘要了臨床創新、供應鏈動態和策略要務之間的相互作用，這些因素將決定主動脈瘤治療的未來成功。

主動脈瘤治療正處於轉折點，技術創新、人口壓力和不斷變化的醫療模式交匯融合，為臨床醫生、製造商和醫療系統帶來了機會和挑戰。微創血管內治療策略的興起正在拓展治療適應症並改變資源分配，器械開發商也正積極推出創新產品，以應對解剖學上的挑戰並確保器械的長期耐用性。同時，包括貿易趨勢和支付方審查在內的商業和政策發展，也影響籌資策略和市場推廣方式。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合影像導引功能的先進血管內主動脈修復裝置的普及
  • 人工智慧演算法在動脈瘤風險分層和監測的應用日益廣泛
  • 對結合開放性手術和血管內治療的微創混合手術的需求日益成長
  • 增加對聚合物塗層技術的投資，以提高血管支架耐久性和生物相容性
  • 擴大遠端醫療和遠端患者監護在主動脈瘤術後監測的應用
  • 用於預測主動脈瘤生長的新型循環生物標記和液態生物檢體檢測方法
  • 重點關注動脈瘤風險管理中的個人化基因檢測和精準醫療方法。
  • 監管和報銷政策的轉變加速了新一代血管支架核准和應用。
  • 人口老化導致主動脈瘤發生率上升，推動了對預防性篩檢計畫的需求。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 主動脈瘤市場：依治療方法

  • 血管內修復
    • 血管支架
  • 開放式手術修復
    • 生物通道
    • 合成血管移植物

9. 主動脈瘤市場（依動脈瘤類型分類）

  • 腹部主動脈血管瘤
    • 腎動脈下方
    • 腎旁
    • 腎上腺上
  • 胸主動脈瘤
    • 上升部分
    • 下降部分
    • 腹部主動脈血管瘤

第10章 主動脈瘤市場（依最終用戶分類）

  • 門診手術中心
    • 心臟病中心
    • 獨立手術中心
  • 醫院
    • 綜合醫院
    • 血管專科中心
    • 三級醫院

第11章 主動脈瘤市場（依器械類型分類）

  • 血管支架
  • 人工血管移植物

第12章 主動脈瘤市場（依適應症分類）

  • 選擇性修復
  • 破裂修復

第13章 依病患年齡層分類的主動脈瘤市場

  • 65歲或以上
  • 65歲以下

第14章 主動脈瘤市場：性別

  • 女士
  • 男性

第15章 各地區主動脈瘤市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 主動脈瘤市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國主動脈瘤市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • WL Gore & Associates, Inc.
    • Cook Medical LLC
    • Endologix, Inc.
    • Terumo Corporation
    • Lombard Medical Inc.
    • Jotec GmbH
    • Bolton Medical Limited
    • Artivion, Inc.
    • MicroPort Scientific Corporation
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market is projected to grow by USD 9.53 billion at a CAGR of 8.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.79 billion
Estimated Year [2025] USD 5.22 billion
Forecast Year [2032] USD 9.53 billion
CAGR (%) 8.97%

An overarching introduction that frames the evolving clinical, technological, and delivery dynamics shaping aortic aneurysm treatment and stakeholder decision-making

Aortic aneurysm management sits at the intersection of surgical innovation, demographic shifts, and evolving healthcare delivery models. Recent years have seen the steady migration of clinical preference toward less invasive therapies, concurrent advances in imaging and device technology, and a heightened emphasis on perioperative risk mitigation. These dynamics converge against a backdrop of an ageing population with rising cardiovascular comorbidity burden, creating sustained clinical demand while simultaneously intensifying the focus on safety, long-term durability, and cost-effective pathways for intervention.

Clinicians and health system leaders are now navigating a more complex therapeutic landscape in which endovascular options must be balanced against open repair approaches based on anatomical suitability, patient frailty, and access-to-care considerations. Device designers are responding with increasingly sophisticated stent graft architectures, refined delivery systems, and adjunctive tools to address challenging anatomies such as short-necked infrarenal aneurysms and complex thoracoabdominal lesions. At the same time, payors and hospital administrators are scrutinizing procedural site selection and resource utilization, prompting closer evaluation of ambulatory surgery centers and streamlined care protocols.

This executive summary synthesizes current clinical trends, regulatory and commercial shifts, and provider-level strategic implications to support clinicians, manufacturers, and investors in making informed decisions. The analysis emphasizes actionable insights into modality choice, device differentiation, end-user adoption patterns, and regional variations that are shaping the path forward for aortic aneurysm care.

An in-depth analysis of how clinical innovation, care setting transitions, and regulatory emphasis are reshaping aortic aneurysm treatment paradigms across stakeholders

The landscape of aortic aneurysm care is undergoing transformative shifts driven by technological maturation, changing care settings, and the reframing of value across stakeholders. Minimally invasive endovascular repair has progressed from a niche alternative to a default option for many anatomies, supported by improved imaging fidelity, navigation systems, and modular stent graft designs that address previously inoperable segments. These advances are complemented by perioperative optimization techniques and enhanced recovery protocols that reduce length of stay and procedural morbidity, thereby altering the calculus of clinical decision-making.

Concurrently, device innovation is moving toward personalized solutions, including fenestrated and branched endografts, low-profile delivery systems, and materials engineered for long-term durability and reduced thrombogenicity. These innovations expand candidacy for endovascular approaches, particularly among older or comorbid patients who would face higher risks with open surgical repair. The shift is not purely technological; it reflects an ecosystem change where multidisciplinary teams, including vascular surgery, interventional radiology, and cardiac surgery, increasingly collaborate to tailor therapy to patient-specific anatomy and risk profiles.

Health systems are also redefining care pathways, directing lower-risk elective procedures to ambulatory settings and employing telemedicine and remote monitoring for follow-up surveillance. This decentralization of care pressures device manufacturers to standardize training, simplify deployment, and ensure consistent outcomes across disparate settings. Lastly, regulatory emphasis on post-market surveillance and real-world evidence is prompting companies to invest in registries and longitudinal studies, which in turn inform clinical guidelines and payer coverage policies. Together, these shifts create both opportunity and competitive pressure for stakeholders to adapt strategy, investment, and product development roadmaps.

A detailed exploration of how the 2025 United States tariff changes have influenced device sourcing, manufacturing strategies, and procurement decisions across the aortic aneurysm ecosystem

Tariff adjustments implemented in the United States in 2025 introduced a new variable into the supply chain calculus for medical device manufacturers, health systems, and distributors involved in aortic aneurysm care. Many devices and components used in endovascular and open surgical repairs are sourced globally, and changes in import duties can result in increased landed costs for stent grafts, synthetic conduits, and ancillary delivery components. These cost pressures ripple through procurement processes, prompting hospital supply chain teams to renegotiate contracts, reassess supplier diversification strategies, and evaluate the feasibility of localizing certain manufacturing or sterilization processes.

The cumulative impact of the tariff measures has prompted manufacturers to reassess their global sourcing footprints, with some prioritizing regional production hubs to mitigate exposure to trade fluctuations. For devices that rely on specialized raw materials or implants produced by a limited set of suppliers, tariffs have amplified the need for transparent cost structures and contingency planning. Health systems facing constrained operating budgets may respond by enhancing value-based contracting, extending device reuse policies within regulatory allowances, or prioritizing procedural modalities that demonstrate stronger cost-effectiveness in their local contexts.

Regulatory and reimbursement bodies have also taken notice, and the interplay between import duties and pricing has the potential to alter negotiations around bundled payments and procedural reimbursement. For international suppliers, tariff-induced pricing changes may slow market entry or shift commercialization timelines, particularly for high-complexity devices that require substantial clinical evidence prior to adoption. Ultimately, the 2025 tariff environment underscores the importance of supply-chain resilience, flexible manufacturing strategies, and closer collaboration between manufacturers and providers to preserve access to life-saving aortic aneurysm interventions while managing economic impacts.

Segment-driven insights that connect treatment modalities, anatomical complexity, care settings, and patient demographics to actionable clinical and commercial strategies

Segmentation analysis reveals distinct clinical pathways and commercial considerations that influence treatment selection, device demand, and provider adoption. Based on treatment modality, clinicians weigh endovascular repair against open surgical repair by considering patient anatomy and physiological resilience; endovascular techniques increasingly leverage stent graft systems with advanced delivery platforms to expand applicability, while open surgical repair continues to rely on both biological conduits and synthetic vascular grafts where durability and specific anatomical requirements dictate approach.

When viewed through the lens of aneurysm type, abdominal aortic aneurysms and thoracic aortic aneurysms present different technical challenges and device requirements. Abdominal presentations are further stratified by infrarenal, juxtarenal, and suprarenal locations, each demanding unique fixation and sealing strategies, whereas thoracic presentations span ascending, descending, and thoracoabdominal segments that often require branched or fenestrated designs to preserve branch vessel integrity. These anatomical distinctions drive product development priorities, imaging protocols, and operator training needs.

End-user segmentation highlights divergent adoption curves and procedural settings. Ambulatory surgery centers, including cardiology-centered facilities and standalone surgery centers, are increasingly attractive for lower-risk, elective interventions that benefit from streamlined throughput and lower overhead. Conversely, hospitals, whether general, specialized vascular centers, or tertiary care institutions, maintain primacy for high-complexity cases and ruptured presentations that require multidisciplinary resources and critical care capabilities.

Device type segmentation isolates stent graft systems and synthetic vascular grafts as core product categories, each with unique regulatory pathways, sterilization requirements, and surgeon preferences. Indication-based segmentation differentiates elective repairs, where optimization of recovery and cost containment are priorities, from rupture repairs, which demand immediate access to robust devices and emergent care pathways. Patient demographics further nuance demand patterns, with an older cohort driving higher procedural volume and anatomical complexity; gender differences shape risk stratification and anatomical fit considerations, necessitating inclusive design and evidence generation across populations.

A regional assessment highlighting how divergent healthcare infrastructures, reimbursement approaches, and clinical practices shape aortic aneurysm care across major global geographies

Regional dynamics produce meaningful variation in clinical practice, infrastructure readiness, and regulatory expectations that affect how aortic aneurysm care is delivered and how products are commercialized. In the Americas, there is a strong emphasis on minimally invasive approaches coupled with robust private and public payer systems; advanced imaging networks and high-volume tertiary centers support rapid adoption of novel endografts and complex fenestrated solutions, while ambulatory settings are progressively absorbing lower-risk elective cases.

Europe, Middle East & Africa present a heterogeneous landscape where western European markets emphasize guideline-driven adoption and centralized specialized vascular centers, and emerging markets across the Middle East and Africa grapple with infrastructure constraints and variable access to advanced devices. Regulatory alignment with regional authorities and investments in training and centers of excellence are critical to expanding reach across these diverse healthcare systems.

Asia-Pacific demonstrates accelerated uptake in innovation in several urbanized markets that combine high procedure volumes with expanding ambulatory infrastructures. Local manufacturing capacities and partnerships with global manufacturers are shaping access and price dynamics, while demographic trends and public health initiatives are increasing screening and early detection efforts. Across regions, differences in reimbursement structures, clinical guideline adoption, and workforce availability create distinct strategic imperatives for manufacturers and providers seeking sustainable growth and clinical impact.

An industry-focused overview of how innovation pipelines, supply chain agility, and evidence generation are shaping competitive differentiation among device manufacturers

Corporate strategy in the aortic aneurysm domain centers on sustained innovation, clinical evidence generation, and operational scale. Leading device developers prioritize investments in next-generation stent graft architectures, low-profile delivery systems, and materials science to improve long-term outcomes and broaden anatomical applicability. Strategic alliances between device innovators and contract manufacturers or imaging technology firms are increasingly common, enabling integrated solutions that combine implant performance with advanced navigation and intraoperative imaging.

Investment in post-market surveillance and real-world data initiatives has become a differentiator, supporting regulatory submissions, payer negotiations, and clinician confidence. Firms that can demonstrate comprehensive training programs, robust customer support, and streamlined logistics achieve higher penetration across ambulatory and hospital settings. Meanwhile, smaller and emerging medtech companies focus on niche innovations-such as branched configurations for complex thoracoabdominal repairs or biologically optimized graft materials-positioning themselves for acquisition or strategic partnerships with larger players.

Supply-chain agility and regional manufacturing presence influence competitive positioning, particularly in areas affected by trade policy shifts. Companies that proactively localize production or diversify supplier networks reduce exposure to tariff volatility and distribution bottlenecks. Additionally, those that invest in digital tools for follow-up surveillance, patient-reported outcomes, and remote monitoring create differentiated value propositions for health systems prioritizing longitudinal care and cost containment.

Actionable strategic recommendations that align product development, supply chain resilience, and value-based commercialization to accelerate adoption and clinical impact

Industry leaders should adopt a multi-pronged strategy that aligns product innovation with care delivery trends, regulatory expectations, and procurement realities. First, prioritize modular and anatomically adaptable device platforms that reduce procedure complexity and expand the pool of patients eligible for less invasive treatment, thereby enabling broader adoption across diverse care settings. Second, invest in robust real-world evidence generation and registries to accelerate payer acceptance, validate long-term safety, and inform iterative product improvements that are grounded in clinical practice realities.

Third, strengthen supply-chain resilience by diversifying supplier bases, exploring regional production hubs, and developing contingency plans for component sourcing to mitigate the impact of trade policy shifts. Fourth, tailor commercial approaches to end-user segmentation by offering targeted training and support programs for ambulatory surgery centers, and by providing integrated clinical pathways for tertiary hospitals managing complex rupture cases. Fifth, collaborate with health systems to pilot bundled-care models and outcome-based contracts that align reimbursement with value delivered, thus improving access while demonstrating cost-effectiveness.

Finally, foster multidisciplinary clinician engagement and invest in education that promotes appropriate patient selection, surveillance protocols, and secondary prevention; this clinician-centric approach supports safer adoption of novel devices and strengthens long-term patient outcomes. These combined actions will position organizations to capture clinical and commercial opportunities while managing operational risks.

A transparent explanation of the blended qualitative and quantitative research approach used to derive clinical, commercial, and supply chain insights for aortic aneurysm care

The research methodology underpinning this executive summary integrates qualitative and quantitative approaches to ensure rigorous, evidence-based insights. Primary inputs include expert interviews with vascular surgeons, interventionalists, hospital procurement leaders, and device regulatory specialists to capture current clinical practice, device preferences, and adoption barriers. These clinician-level perspectives are supplemented by discussions with supply-chain and commercial leaders to understand manufacturing considerations, distribution dynamics, and the implications of recent trade policies.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and professional society position statements to validate clinical trends and device-specific performance characteristics. Where appropriate, registry data and published post-market surveillance reports were analyzed to assess safety signals and durability considerations, and findings were triangulated across multiple sources to enhance robustness. The segmentation framework was applied to map product types, indications, end-user settings, and patient cohorts to ensure that insights reflect the diversity of clinical pathways and commercial channels.

Finally, analytic rigor was maintained through cross-validation of thematic findings with independent experts and iterative refinement of conclusions to reflect both clinical nuance and commercial realism. This blended methodology supports actionable recommendations while acknowledging areas where evidence remains emergent and where ongoing surveillance will be required.

A concise conclusion summarizing the interplay of clinical innovation, supply chain dynamics, and strategic imperatives that will determine future success in aortic aneurysm care

Aortic aneurysm care is at an inflection point where technological innovation, demographic pressures, and changing care models intersect to create both opportunity and complexity for clinicians, manufacturers, and health systems. The move toward minimally invasive endovascular strategies is broadening treatment candidacy and shifting resource allocation, while device developers respond with targeted innovations that address anatomical challenges and long-term durability. At the same time, commercial and policy developments, including trade dynamics and payer scrutiny, are influencing procurement strategies and go-to-market approaches.

Stakeholders that align product development with clinical evidence, invest in training and post-market surveillance, and build resilient supply chains will be best positioned to deliver patient-centered outcomes while achieving sustainable commercial performance. Embracing collaborative models with health systems and payers that emphasize value and outcomes will further enable access to advanced therapies and support the long-term viability of innovative solutions. As the landscape continues to evolve, continued monitoring of clinical data, regulatory developments, and regional care models will be essential to refine strategies and maintain alignment with emerging best practices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in advanced endovascular aortic repair devices with integrated imaging guidance
  • 5.2. Increasing adoption of artificial intelligence algorithms for aneurysm risk stratification and monitoring
  • 5.3. Rising demand for minimally invasive hybrid procedures combining open and endovascular techniques
  • 5.4. Growing investment in polymer coating technologies to enhance stent graft durability and biocompatibility
  • 5.5. Expansion of telemedicine and remote patient monitoring for post-operative aortic aneurysm surveillance
  • 5.6. Emergence of novel circulating biomarkers and liquid biopsy assays for aneurysm growth prediction
  • 5.7. Focus on personalized genetic testing and precision medicine approaches in aneurysm risk management
  • 5.8. Regulatory and reimbursement policy shifts accelerating approval and adoption of next-gen stent grafts
  • 5.9. Rising incidence of aortic aneurysms in aging populations driving demand for preventive screening programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Aneurysm Market, by Treatment Modality

  • 8.1. Endovascular Repair
    • 8.1.1. Stent Graft
  • 8.2. Open Surgical Repair
    • 8.2.1. Biological Conduit
    • 8.2.2. Synthetic Vascular Graft

9. Aortic Aneurysm Market, by Aneurysm Type

  • 9.1. Abdominal Aortic Aneurysm
    • 9.1.1. Infrarenal
    • 9.1.2. Juxtarenal
    • 9.1.3. Suprarenal
  • 9.2. Thoracic Aortic Aneurysm
    • 9.2.1. Ascending
    • 9.2.2. Descending
    • 9.2.3. Thoracoabdominal

10. Aortic Aneurysm Market, by End User

  • 10.1. Ambulatory Surgery Centers
    • 10.1.1. Cardiology Centers
    • 10.1.2. Standalone Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. General Hospitals
    • 10.2.2. Specialized Vascular Centers
    • 10.2.3. Tertiary Care Hospitals

11. Aortic Aneurysm Market, by Device Type

  • 11.1. Stent Graft
  • 11.2. Synthetic Vascular Graft

12. Aortic Aneurysm Market, by Indication

  • 12.1. Elective Repair
  • 12.2. Rupture Repair

13. Aortic Aneurysm Market, by Patient Age Group

  • 13.1. 65 And Above
  • 13.2. Under 65

14. Aortic Aneurysm Market, by Gender

  • 14.1. Female
  • 14.2. Male

15. Aortic Aneurysm Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Aortic Aneurysm Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Aortic Aneurysm Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. W. L. Gore & Associates, Inc.
    • 18.3.3. Cook Medical LLC
    • 18.3.4. Endologix, Inc.
    • 18.3.5. Terumo Corporation
    • 18.3.6. Lombard Medical Inc.
    • 18.3.7. Jotec GmbH
    • 18.3.8. Bolton Medical Limited
    • 18.3.9. Artivion, Inc.
    • 18.3.10. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AORTIC ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MIL